Nevertheless, chromosome 7 polysomy harbours prognostic value in the context of EGFR TKI therapy in NSCLC patients55, 56, 57, 58 and therefore has potential therapeutic relevance in this patient population. Here, EGFR is linked to non-small cell lung carcinoma.